FRISCO, TX— OXYS, (Marketwired – January 26, 2016) – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative medical solutions today announced that the Company has partnered with MedOne Capital, the premier leasing provider of medical equipment in the United States to provide OxySure customers easy, fast and flexible financing of medical devices. Julian Ross, Chairman and CEORead more
- Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated
- Pura Naturals Launches New Line of Health and Beauty Products with CBD and Hemp Seed Oils
- Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery
- Sugarmade to Offer Revenue Guidance on March 30th for Rapid Cannabis Sector Growth – Begins to Recognize Revenues From Multiple New Revenue Streams
- Sack Lunch Productions Reduces Debt by an Estimated $2M in Q1
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More